Related Experiment Video
Updated: May 16, 2025
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies
Zhiwei Han1, Guomin Chen2, Dongchen Wang1
1Department of Orthopedics, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Abstract:
Osteosarcoma remains a highly aggressive bone malignancy with limited therapeutic options, necessitating novel treatment strategies. Immunotherapy has emerged as a promising approach, yet its efficacy in osteosarcoma is hindered by an immunosuppressive tumor microenvironment and resistance mechanisms. This review explores recent advancements in checkpoint blockade, cellular therapies, and combination strategies aimed at enhancing immune responses. We highlight key challenges, including tumor heterogeneity, poor immune infiltration, and the need for predictive biomarkers. By integrating immunotherapy with chemotherapy, radiotherapy, and targeted therapy, emerging approaches seek to improve treatment outcomes. This review provides a comprehensive analysis of the evolving landscape of osteosarcoma immunotherapy, offering insights into future directions and potential breakthroughs. Researchers and clinicians will benefit from understanding these developments, as they pave the way for more effective and personalized therapeutic strategies in osteosarcoma.
Insights
Immunotherapy shows promise for aggressive osteosarcoma but faces challenges. Combining immune treatments with traditional therapies may improve outcomes for this bone cancer.
Area of Science:
- Oncology
- Immunology
- Bone Cancer Research
Background:
- Osteosarcoma is an aggressive bone cancer with limited treatment options.
- Current immunotherapies face challenges due to the tumor microenvironment and resistance.
- Novel strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To review recent advancements in osteosarcoma immunotherapy.
- To explore challenges and potential solutions in enhancing immune responses.
- To provide insights into future therapeutic directions.
Main Methods:
- Review of current literature on osteosarcoma immunotherapy.
- Analysis of checkpoint blockade, cellular therapies, and combination strategies.
- Identification of key challenges and emerging biomarkers.
Main Results:
- Immunotherapy efficacy is limited by immunosuppressive tumor microenvironments.
- Combination strategies integrating immunotherapy with other treatments show potential.
- Addressing tumor heterogeneity and immune infiltration is critical.
Conclusions:
- Advancements in immunotherapy offer new hope for osteosarcoma treatment.
- Personalized therapeutic strategies are essential for overcoming resistance.
- Further research is needed to optimize combination approaches and biomarkers.
Related Concept Videos
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...